NO952208L - Amin-derivater - Google Patents

Amin-derivater

Info

Publication number
NO952208L
NO952208L NO952208A NO952208A NO952208L NO 952208 L NO952208 L NO 952208L NO 952208 A NO952208 A NO 952208A NO 952208 A NO952208 A NO 952208A NO 952208 L NO952208 L NO 952208L
Authority
NO
Norway
Prior art keywords
alkyl
optionally substituted
halogen
phenyl
saturated
Prior art date
Application number
NO952208A
Other languages
English (en)
Norwegian (no)
Other versions
NO952208D0 (no
Inventor
Duncan Robert Armour
Philip Charles Box
Pritom Shah
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO952208D0 publication Critical patent/NO952208D0/no
Publication of NO952208L publication Critical patent/NO952208L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO952208A 1992-12-05 1995-06-02 Amin-derivater NO952208L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225492A GB9225492D0 (en) 1992-12-05 1992-12-05 Amine derivatives
PCT/EP1993/003381 WO1994013648A1 (en) 1992-12-05 1993-12-02 1,4-benzodiazepine derivatives and their use as cck-modulators

Publications (2)

Publication Number Publication Date
NO952208D0 NO952208D0 (no) 1995-06-02
NO952208L true NO952208L (no) 1995-08-02

Family

ID=10726205

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952208A NO952208L (no) 1992-12-05 1995-06-02 Amin-derivater

Country Status (29)

Country Link
US (1) US5569654A (cs)
EP (1) EP0672037B1 (cs)
JP (1) JPH08504200A (cs)
KR (1) KR950704270A (cs)
CN (1) CN1093085A (cs)
AT (1) ATE168102T1 (cs)
AU (1) AU688295B2 (cs)
BG (1) BG99696A (cs)
BR (1) BR9307580A (cs)
CA (1) CA2150461A1 (cs)
CZ (1) CZ138495A3 (cs)
DE (1) DE69319614D1 (cs)
EC (1) ECSP941085A (cs)
FI (1) FI952709A7 (cs)
GB (1) GB9225492D0 (cs)
HU (1) HUT71339A (cs)
IL (1) IL107869A (cs)
MX (1) MX9307654A (cs)
NO (1) NO952208L (cs)
NZ (1) NZ258874A (cs)
OA (1) OA10161A (cs)
PE (1) PE54294A1 (cs)
PL (1) PL309281A1 (cs)
RO (1) RO114446B1 (cs)
RU (1) RU95114528A (cs)
SK (1) SK74195A3 (cs)
TW (1) TW237450B (cs)
WO (1) WO1994013648A1 (cs)
ZA (1) ZA939068B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
US5428157A (en) * 1993-11-22 1995-06-27 Merck & Co., Inc. 3-acylaminobenzodiazepines
WO1995028399A1 (en) * 1994-04-15 1995-10-26 Glaxo Wellcome Inc. A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
AUPO284396A0 (en) * 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
WO1998046591A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
EP0977773A1 (en) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6204268B1 (en) 1997-04-14 2001-03-20 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6333321B1 (en) * 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6100254A (en) * 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
KR100911779B1 (ko) * 2001-05-25 2009-08-12 세파론, 인코포레이티드 모다피닐을 포함하는 고형 제약 제제
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
JP2008523072A (ja) * 2004-12-07 2008-07-03 ルーカス ファーマシューティカルズ, インコーポレイテッド タンパク質キナーゼの阻害剤
US7741479B2 (en) * 2004-12-07 2010-06-22 Locus Pharmaceuticals, Inc. Urea inhibitors of MAP kinases
JP2009522363A (ja) * 2006-01-04 2009-06-11 ローカス ファーマシューティカルズ、インク. プロテインキナーゼの阻害剤
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032226A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents

Also Published As

Publication number Publication date
MX9307654A (es) 1994-06-30
GB9225492D0 (en) 1993-01-27
PL309281A1 (en) 1995-10-02
JPH08504200A (ja) 1996-05-07
KR950704270A (ko) 1995-11-17
DE69319614D1 (de) 1998-08-13
OA10161A (en) 1996-12-18
ECSP941085A (es) 1994-12-15
US5569654A (en) 1996-10-29
FI952709A0 (fi) 1995-06-02
CA2150461A1 (en) 1994-06-23
CN1093085A (zh) 1994-10-05
BR9307580A (pt) 1999-06-29
ATE168102T1 (de) 1998-07-15
RU95114528A (ru) 1997-06-10
EP0672037B1 (en) 1998-07-08
IL107869A0 (en) 1994-04-12
RO114446B1 (ro) 1999-04-30
AU5694894A (en) 1994-07-04
WO1994013648A1 (en) 1994-06-23
EP0672037A1 (en) 1995-09-20
ZA939068B (en) 1994-08-09
BG99696A (bg) 1996-01-31
AU688295B2 (en) 1998-03-12
SK74195A3 (en) 1995-11-08
CZ138495A3 (en) 1995-12-13
IL107869A (en) 1998-10-30
NZ258874A (en) 1996-09-25
FI952709A7 (fi) 1995-08-01
TW237450B (cs) 1995-01-01
HU9501622D0 (en) 1995-08-28
PE54294A1 (es) 1995-01-06
NO952208D0 (no) 1995-06-02
HUT71339A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
NO952208L (no) Amin-derivater
MX9203249A (es) Derivados del acido bencimidazolin-2-oxo-1-carboxilico y composiciones farmaceuticas que los contienen.
DK0442820T3 (da) Benzimidazol- og azabenzimidazolderivater, som er thromboxan-receptor-antagonister, fremgangsmåder til deres fremstilling, syntesemellemprodukter og farmaceutiske præparater med indhold deraf
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
NO975987L (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
HUP0203787A2 (hu) Hidroxi-acetil-piperazinnal szubsztituált oxazolidinon-benzoesav-észterek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK393486D0 (da) Dihydropyridin-derivater og fremgangsmaade til fremstilling deraf
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
EA200101181A1 (ru) Циклотиокарбаматные производные в качестве модуляторов рецептора прогестерона
DK333380A (da) Fremgangsmaade til fremstilling af 3-amino-1-benzoxepin-derivater eller syreadditionssalte deraf
DK0712406T3 (da) Kondenserende indolderivater som 5-HT4-receptorantagonister
TR200103286T2 (tr) Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri
ATE914T1 (de) Heterocyclische spiroverknuepfte amidine, ihre stereoisomeren und optischen isomeren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
CO5580819A2 (es) Nuevos derivados propionicos b-fenil-a-oxisubstituidos: proceso para su preparacion y su uso en la preparacion de copmpuestos farmaceuticamente importantes